| Pharmaceutical composition for treating nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis, comprises ursodeoxycholic acid, lobeglitazone, and excipients | |
| 2023-10-04 | |
| 专利权人 | AKUMS DRUGS & PHARM LTD (AKUM-Non-standard) |
| 申请日期 | 2023-10-04 |
| 专利号 | IN202311066690-A |
| 成果简介 | NOVELTY - Pharmaceutical composition comprises 40-90 wt.% ursodeoxycholic acid or its salt, 0.05-10 wt.% lobeglitazone or its salt, and excipients. USE - Pharmaceutical composition for treating nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis. No biological data given. ADVANTAGE - The pharmaceutical composition contains ursodeoxycholic acid, which exhibits both immediate and sustained drug release profile, and lobeglitazone, which exhibits immediate drug release profile, and this dual-action approach may provide improved therapeutic outcomes, potentially leading to better liver health and metabolic control in affected patients. |
| IPC 分类号 | A61K-031/427 ; A61K-031/506 ; A61K-031/575 ; A61K-047/38 ; A61K-009/00 ; A61K-009/14 ; A61K-009/20 ; A61P-001/16 |
| 国家 | 印度 |
| 专业领域 | 医药卫生 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/20134 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | AKUMS DRUGS & PHARM LTD (AKUM-Non-standard) |
| 推荐引用方式 GB/T 7714 | KUMAR S A,ARUN C,SUNIL J,et al. Pharmaceutical composition for treating nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis, comprises ursodeoxycholic acid, lobeglitazone, and excipients. IN202311066690-A[P]. 2023. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论